Exploring health providers’ and community perceptions and experiences with malaria tests in South-East Nigeria: a critical step towards appropriate treatment

Abstract

BackgroundThe adoption of ACT as the first line treatment for uncomplicated malaria in Nigeria has concentrated attention on the role of testing in appropriate malaria treatment. There are calls at both national and global level for malaria treatment to be based on test result, but it is still unclear how testing can be incorporated into treatment-seeking and practices of health providers. This study explored community members and health providers’ perceptions and experiences with malaria tests in south east Nigeria.MethodsThe study was conducted in urban and rural areas of Enugu state in south-eastern Nigeria. A total of 18 focus group discussions with 179 community members including sub-groups of primary caregivers, adult men and adult women aged 15 years and above. Twenty- six (26) In-depth interviews were held with public and private health providers involved in prescribing medicines at public and private health facilities in the study area.ResultsBoth providers and community members were familiar with malaria tests and identified malaria tests as an important step to distinguish malaria from other illnesses with similar symptoms and as a means of delivering appropriate treatment. However, the logic of test-directed treatment was undermined by cost of test and a lack of testing facilities but above all concerns over the reliability of negative test results, with community members and providers observing inconsistencies between results and symptoms, and providers attributing inaccurate results to incompetencies of technicians. Recognition of malaria symptoms was deemed most important in determining the use of antimalarial drugs rather than the result of a malaria test.ConclusionThe results highlight important areas of intervention to promote appropriate malaria treatment. If tests are to play a role in patient management, demand and supply side interventions are needed to change people’s attitude towards malaria test results.

Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings

“…[44][45][46][47] Results of the individual trials were disseminated to IQR=interquartile range. *Proportion of patients testing positive for malaria (among those in intervention settings who were tested) presented as proxy for malaria epidemiology.…”

Cost benefit analysis of malaria rapid diagnostic test: the perspective of Nigerian community pharmacists

“…This is similar to the situation in Nigeria, in which nearly 60% of Nigerians seek treatment for malaria at drug shop outlets in the private health sector, composed of licensed community pharmacies (or referred to as pharmacies) and loosely regulated proprietary and patent medicine vendors (PPMV) [15, 28, 29]. This treatment-seeking behaviour is attributed to patients’ convenience, availability of familiar drugs, affordability, reduced waiting hour and proximity [30]. …”

Getting antimalarials on target: impact of national roll‐out of malaria rapid diagnostic tests on health facility treatment in three regions of Tanzania

“…Other studies have similarly reported less-than-optimal coverage of diagnostic tests (Hamer et al 2007;Nyandigisi et al 2011;Masanja et al 2012). In addition to poor diagnostic availability (Ezeoke et al 2012), reasons for poor coverage may include inadequate health worker training, negative health worker perceptions of mRDTs, provider workload or patient preferences (Chandler et al 2008a;Williams et al 2008;Asiimwe et al 2012;Baiden et al 2012). Health centre and dispensary patients paid a flat rate for treatment, so patient willingness-to-pay for tests is not expected to have been a factor in these facilities, but may have contributed in hospital settings where separate fees were sometimes charged for diagnostics.…”

“…; Ezeoke et al . ). While some studies have reported poor compliance with negative test results (Hamer et al .…”

“…In addition to poor diagnostic availability (Ezeoke et al . ), reasons for poor coverage may include inadequate health worker training, negative health worker perceptions of mRDTs, provider workload or patient preferences (Chandler et al . ; Williams et al .…”